Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
I
117TH CONGRESS
1ST SESSION H. R. 2934
To amend title XVIII of the Social Security Act to remove from the list
of drugs excluded from coverage under the Medicare prescription drug
program prescription oral vitamins and mineral products indicated for
the treatment of iron deficiency anemia in individuals with chronic kidney
disease.
IN THE HOUSE OF REPRESENTATIVES
APRIL 30, 2021
Mr. O’HALLERAN (for himself, Mr. BUCSHON, Mr. BUTTERFIELD, and Mr.
MULLIN) introduced the following bill; which was referred to the Com-
mittee on Energy and Commerce, and in addition to the Committee on
Ways and Means, for a period to be subsequently determined by the
Speaker, in each case for consideration of such provisions as fall within
the jurisdiction of the committee concerned
A BILL
To amend title XVIII of the Social Security Act to remove
from the list of drugs excluded from coverage under
the Medicare prescription drug program prescription oral
vitamins and mineral products indicated for the treat-
ment of iron deficiency anemia in individuals with chron-
ic kidney disease.
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled,
2
VerDate Sep 11 2014
05:08 Jun 09, 2021
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H2934.IH
H2934
kjohnson on DSK79L0C42PROD with BILLS
2
•HR 2934 IH
SECTION 1. SHORT TITLE.
1
This Act may be cited as the ‘‘Renal Anemia Innova-
2
tion Support and Expansion Act’’ or the ‘‘RAISE Act’’.
3
SEC. 2. REMOVING CERTAIN PRESCRIPTION VITAMINS AND
4
MINERAL PRODUCTS FROM THE LIST OF
5
DRUGS EXCLUDED FROM COVERAGE UNDER
6
THE MEDICARE PRESCRIPTION DRUG PRO-
7
GRAM.
8
Section 1860D–2(e)(2)(A) of the Social Security Act
9
(42 U.S.C. 1395w–102(e)(2)(A)) is amended by inserting
10
‘‘other than subparagraph (F) of such section (relating to
11
prescription vitamin and mineral products, except prenatal
12
vitamins and fluoride preparations) if the prescription vi-
13
tamin or mineral product is orally administered and is in-
14
dicated for treatment of iron deficiency anemia in individ-
15
uals with chronic kidney disease,’’ after ‘‘other than sub-
16
paragraph (E) of such section (relating to smoking ces-
17
sation agents),’’.
18
Æ
VerDate Sep 11 2014
05:08 Jun 09, 2021
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6301
E:\BILLS\H2934.IH
H2934
kjohnson on DSK79L0C42PROD with BILLS